Harvard Medical School

Entry	Author	Date	Location
Paul Allen Commits $300M to Expand Institute for Brain Science	Luke Timmerman	03/21/12	Seattle
The Herman Cain-Inspired “1-100-0″ Plan for Personalized Medicine?	Luke Timmerman	11/14/11	National
OvaScience Uses Stem Cells to Revive Fertility	Arlene Weintraub	10/12/11	Boston
Pulmatrix Snags $14M, Embera Adds for $4.5 Addiction Drugs, Daktari Gets $1.2M, & More Boston-Area Life Sciences News	Erin Kutz	08/19/11	Boston
PacBio, Following Fast Behind Rivals, Seeks Answers for Germany’s E.Coli Outbreak	Luke Timmerman	07/27/11	San Francisco
Organovo’s Bio-Printing Technology Yields Unanticipated Revenue from Pharma Partners	Bruce V. Bigelow	07/13/11	San Diego
Rock Health, A New Incubator for Healthcare IT Startups, Names Its First Class	Wade Roush	06/02/11	San Francisco
PerkinElmer Acquires Geospiza, Beefing Up Software for DNA Analysis	Luke Timmerman	05/05/11	Seattle
NYC’s Vivaldi, Allied With Harvard and San Francisco VC Firm, Forge a New Way to Fight the Flu	Arlene Weintraub	04/28/11	New York
KEW, Led by Millennium Co-Founder, Seeks to Bring Big-Time Cancer Care to Community Clinics	Ryan McBride	04/27/11	Boston
NeuroPhage Nets $12.4M to Tackle Alzheimer’s and Other Brain Disorders	Gregory T. Huang	03/01/11	Boston
Pervasis in “Advanced” Talks with Potential Partners for Blood-Vessel Healing Product, CEO Says	Ryan McBride	02/01/11	Boston
Onyx Takes a Swing at Myeloma, PacBio Hits Haitian Cholera Genome, Sequenta Nabs $13M, & More Bay Area Life Sciences News	Luke Timmerman	12/10/10	San Francisco
PacBio, Harvard Use Fast Gene Sequencer to Crack DNA Code of Haitian Cholera Strain	Luke Timmerman	12/09/10	San Francisco
MedNetworks Taps UCSD’s James Fowler and Other Experts for New Scientific Board	Ryan McBride	12/09/10	Boston
$20M Series A For Karyopharm to Fight Cancer	Erin Kutz	11/03/10	Boston
The Future of Health IT—Video Clips From Athenahealth’s Jonathan Bush & Others at Xconomy Debate	Robert Buderi	11/01/10	Boston
CalciMedica Charges Ahead Toward First Human Test of Oral Pill for Psoriasis	Luke Timmerman	10/20/10	San Diego
Merck Ends Aveo Deal, Acceleron Rides Pharma Partnership Wave, Rhythmia Raises $5M, & More Boston-Area Life Sciences News	Rebecca Zacks	10/01/10	Boston
Good Start Genetics Emerges from Stealth with $18M Series A Round	Ryan McBride	09/10/10	Boston
Aileron Inks Deal with Roche, Worth Up to $1.1B, to Develop Stapled Peptide Drugs	Gregory T. Huang	08/24/10	Boston
Agios, Nourished with $130M Celgene Deal, Expanding Staff and Labs to Starve Cancer	Ryan McBride	08/19/10	Boston
Former Sirtris Execs’ Nonprofit Starts Selling Resveratrol with Potential Anti-Aging Effects Online	Ryan McBride	08/12/10	Boston
Boston’s Autism Mini-Cluster: New Drugs and Diagnostics Target Mysterious Brain Disorders	Ryan McBride	07/22/10	Boston
Adimab Inks Novartis Deal, GSK-Founded Tempero Pursues Hot Immunology Field, Metamark Gets $22M, & More Boston-Area Life Sciences News	Erin Kutz	07/16/10	Boston
Glaxo’s Tempero Pharma Advances on Hot Niche of Immunology	Ryan McBride	07/15/10	Boston
ThredUP Funded by New Micro VC Firm, Visterra Grabs $6M, Vivox Gets $2M From Peacock Equity, & More Boston-Area Deals News	Erin Kutz	07/14/10	Boston
Metamark Genetics Raises $22M to Find Genetic Signs of Tumor Progression	Ryan McBride	07/13/10	Boston
Amazon’s Cloud Computing Service Sees Opportunity in Genomic Data Overload	Luke Timmerman	07/06/10	National
Former J&J Group Chairman’s Firm Backs BIND Biosciences in $12.4M Round	Ryan McBride	06/29/10	Boston
Page 1 of 4	next page »

Entry

Author

Date

Location

Paul Allen Commits $300M to Expand Institute for Brain Science

Luke Timmerman

03/21/12

Seattle

The Herman Cain-Inspired “1-100-0″ Plan for Personalized Medicine?

Luke Timmerman

11/14/11

National